Collplant Biotechnologies LTD F-1 registration statements

CollPlant Biotechnologies registers up to 3.296 million ordinary shares for resale by selling shareholders following a February 2026 private placement.

CollPlant Biotechnologies Ltd. has filed an F-1 registration statement to allow selling shareholders to resell up to 1,272,002 ordinary shares, primarily from a recent private placement, with the company not receiving direct proceeds from these resales but potentially from warrant exercises.